Biotech and Pharmaceuticals
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
Artur Widak | Nurphoto | Getty Images Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial in adults ages 50 and above this year after showing positive results in an early to mid-stage study. The biotech company hopes its shot, mRNA-1083, can win approval from […]
Read More
Novartis unit Sandoz set to start trading after completing spinoff
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Bloomberg | Bloomberg | Getty Images Novartis has completed the spinoff of its generics and biosimilars business Sandoz, which is set to debut trading on the SIX Swiss Exchange on Wednesday. The […]
Read More
FDA approves updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters The Food and Drug Administration on Tuesday approved Novavax‘s updated Covid vaccine under emergency use, putting the shot on track to roll out weeks after new jabs from Pfizer and Moderna reached Americans. Novavax’s new […]
Read More
Drugmakers opt in to Medicare drug price negotiations – here’s what happens next
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, even after many of them sued to halt the […]
Read More
Kaiser Permanente union workers poised to strike after contract expires
A sign is posted on the exterior of the Kaiser Permanente Vallejo Medical Center on September 08, 2023 in Vallejo, California. Justin Sullivan | Getty Images More than 75,000 workers at the largest nonprofit private health-care provider in the United States are poised to strike Wednesday after negotiations failed to reach an agreement over the […]
Read More
Federal judge declines to block Medicare drug price negotiations
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on Friday declined to block the Biden administration from implementing Medicare drug price negotiations, upholding for now a controversial process that aims to make costly medications […]
Read More
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
Aykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup’s experimental obesity pill succeeded in a small early-stage trial. The once-daily drug helped overweight or obese participants reduce up to 10 pounds of weight on average after four weeks of treatment, according to a […]
Read More
We’re set to receive shares in Danaher’s separated water business. Here’s our plan for the new stock
Danaher (DHR) is days away from shedding its environmental-and-applied solutions segment, and the Club holding’s ability to deliver returns for shareholders appears stronger than ever. Those potential returns can come from two places: Danaher stock and shares of Veralto (VLTO), the soon-to-be-standalone company that’s in the business of water quality. We see underappreciated value in […]
Read More
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
A view of a plastic model of a stomach during an interview with Doctor Thomas Horbach, specialist in surgery, visceral surgery and nutritional medicine on Novo Nordisk, which will start selling its hugely popular obesity drug Wegovy in Germany later this month, in Munich, Germany, July 17, 2023. Christine Uyanik | Reuters Drugmakers spent nearly […]
Read More
Schott Pharma shares trade all over 30 euros in debut, over listing price
Schott Pharma debuted on the Frankfurt stock exchange on Thursday at 30 euros for each share, trading effectively higher than analyst anticipations. Shares of the business had been up 10% in the first minutes. The healthcare vial manufacturer established its closing present value at 27 euros ($28.37) per share Wednesday, just after the firm introduced […]
Read More